Skip to main content
Search
Main content

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Associations of <sup>18</sup>F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum

Authors
Mahnaz Shekari, Armand González Escalante, Marta Milà-Alomà, Carles Falcon, David López-Martos, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, Aida Niñerola-Baizán, Nicholas J Ashton, Thomas K Karikari, Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Anniina Snellman, Theresa A Day, Jeffrey L Dage, Paula Ortiz-Romero, Matteo Tonietto, Edilio Borroni, Gregory Klein, Gwendlyn Kollmorgen, Margherita Carboni, Clara Quijano-Rubio, Eugeen Vanmechelen, Carolina Minguillón, Karine Fauria, Andrés Perissinotti, José Luis Molinuevo, Henrik Zetterberg, Kaj Blennow, Oriol Grau-Rivera, Marc Suárez-Calvet, Juan Domingo Gispert, ALFA Study
Associations of <sup>18</sup>F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum
HIV medicine
Published

Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART

Authors
Merle Henderson, Peter Dutey-Magni, Carolina Herrera, Wolfgang Stöhr, Alejandro Arenas-Pinto, Owen Swann, Amanda Heslegrave, Henrik Zetterberg, John Tregoning, Sarah Fidler, François Raffi, Andrea Calcagno, Ab Babiker, Alan Winston
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia